Advertisement
Table 2 Clinical efficacy data at final analysis on 43 patients
| Number of cycles (median - range) | 5 [1 - 21] |
| Treatment response (n - %) | |
| CR | 1/43 – 2.3% |
| PR | 7/43 - 16.3% |
| SD | 17/43 - 39.5% |
| PD | 18/43 - 41.9% |
| Clinical benefit | 25/43 - 58.1% |
| ORR | 8/43 - 18.6% |
| TTP (median - range) | 5 [2 - 21] months |
| OS (median - range) | 9 [3 - 29] months |
| Percentage of alive patients (n - %) | |
| year 1 | 16/43 - 37.2% |
| year 2 | 4/43 - 9.3% |
